As of 01 July 2016, all new adult oncology studies will be required to follow the HREBA Cancer Committee main consent template, which is now posted. Study teams are welcome to begin using the new template at any time before 01 July, after which point it will become mandatory.
To assist researchers whose studies also require approvals from Alberta Health Services (AHS) or Covenant Health for the use of their resources for research purposes (e.g., facilities, equipment, staff, patients or their records and systems), the Health Research Ethics Board of Alberta (HREBA) at Alberta Innovates (AI) is allowing AHS and Covenant Health access to the IRISS system. Access is being granted in order to facilitate applicable organizational approvals. This new agreement will streamline processes and eliminate duplication, resulting in greater efficiency. Please note this does not apply to purchasing AHS lab services for study purposes, as there are separate service provider agreements that are to be completed. More information is available here.
The HREBA Cancer Committee is now receiving all new adult and pediatric cancer studies from across Alberta which require ethics review. This significant step continues the harmonization of the work of Alberta’s research ethics boards.
Studies which have been approved by other ethics boards in the province will be transferred to HREBA during April 2016. More information is available in this background document.
To assist researchers whose studies, in addition to ethics review, also require approvals from Alberta Health Services (AHS) or Covenant Health, the Health Research Ethics Board of Alberta (HREBA) at Alberta Innovates (AI) is providing AHS and Covenant Health with expanded access to the IRISS system.
This new agreement will streamline processes and eliminate duplication and result in greater efficiency.